Cite
HARVARD Citation
Shimazu, Y. et al. (2022). Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. Therapeutic advances in hematology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shimazu, Y. et al. (2022). Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. Therapeutic advances in hematology. p. . [Online].